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The purpose of the work was to assess the incidence of potential drug interactions (pDDI), major pDDI, and 
the use of potentially inappropriate medication (PIM) at hospital admission, during hospitalization, and at 
discharge to evaluate whether hospital admission provides an opportunity for improving pharmacotherapy 
in elderly patients at a University hospital that has a clinical pharmacist. A prospective cohort study 
was carried out using data from the medical records of patients admitted to an internal medicine ward. 
All admissions and prescriptions were monitored between March and August 2006. Micromedex® 
DrugReax® and Beers Criteria 2015 were used to identify pDDI, major pDDI, and PIMs, respectively. A 
comparison of admission and discharge prescriptions showed the following: an increase in the proportion 
of patients using antithrombotic agents (76 versus 144; p<0.001), lipid modifying agents (58 versus 
81; p=0.024), drugs for acid-related disorders (99 versus 152; p<0.001), and particularly omeprazole 
(61 versus 87; p=0.015); a decrease in the number of patients prescribed psycholeptics (73 versus 32; 
p<0.001) and diazepam (54 versus 13; p<0.001); and a decrease in the proportion of patients exposed to 
polypharmacy (16.1% versus 10.1%; p=0.025), at least one pDDI (44.5% versus 32.8%; p=0.002), major 
pDDI (19.9% versus 12.2%; p=0.010) or PIM (85.8% versus 51.9%; p<0.001). The conclusion is that 
admission to a hospital ward that has a clinical pharmacist was associated with a reduction in the number 
of patients exposed to polypharmacy, pDDI, major pDDI, and the use of PIMs among elderly inpatients. 
Uniterms:. Health Services/elderly patients. Internal Medicine/hospitals. Clinical Pharmacy. Drug 
interactions. Drug prescriptions.
INTRODUCTION
A general  decline in global fert i l i ty rates, 
improvements in health conditions, increased income, 
and advancements in diagnostic and pharmaceutical 
technology have been associated with an increase in 
life expectancy and greater use of health services and 
medicines for the treatment of chronic and degenerative 
diseases. It is estimated that Brazil will have the sixth 
largest elderly population in the world by 2025 (OMS, 
2005).
The impact of natural physiological changes on 
pharmacodynamic and pharmacokinetic drug processes 
has been correlated with an exaggerated or inappropriate 
response to medication or even an absence of health 
benefits for given drugs (Marengoni et al., 2011). These 
facts have aroused extensive concern about the appropriate 
use of medication in older patients.
Several factors contribute to adverse drug events 
(ADE) in the elderly, ranging from unnecessary drug use 
and inappropriate drug choice to the lack of long-term 
therapy reassessment, inadequate dosage regimens, and 
therapeutic duplication (AGS, 2015; Hubbard, O’Mahony, 
Woodhouse, 2013; Sichieri et al., 2013). In an attempt to 
prevent or at least minimize ADE in the elderly, many 
guides about potential ADE have been created to help 
clinicians choose the best therapeutic option. The most 
frequently used list for older adults is the Beer’s List 
(AGS, 2015; Hubbard, O’Mahony, Woodhouse, 2013; 
Sichieri et al., 2013).
Adverse drug events are common and ADE 
prevention plays a significant role in patient safety, 
particularly among hospitalized patients. According to 
Pirmohamed et al. (2004), 1% of all hospital admissions 
are caused by drug–drug interactions (DDIs), accounting 
for 16% of all hospital admissions due to adverse drug 
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reactions (ADR) in United States (Pirmohamed et al., 2004). 
In the US, increased hospital costs associated with ADR 
were around U$4,700 per admission, resulting in an annual 
estimated cost of $2 billion to the country (Bates, 1995).
While the use of medication among the elderly 
is a conscious decision, research has shown that a total 
reduction in the use of prescription drugs would lead to a 
corresponding decrease in the incidence of ADE (Hubbard, 
O’Mahony, Woodhouse, 2013; Sichieri et al., 2013). Older 
people are major consumers of medications. The number 
of prescriptions for older patients is approximately 3.6 
times times higher than that for younger adults and as such 
they are much more exposed to drug-related problems 
(Pasina et al., 2013). The use of multiple medications by 
a single patient (polypharmacy) has been associated with 
a higher incidence of potentially harmful drug interactions 
(Egger, Drewe, Schlienger, 2003; Marengoni et al., 2014; 
Vonbach et al., 2008).
Changes in drug therapy during hospital admission 
or discharge have been related to an increase in the use of 
prescription drugs, which leads to a greater likelihood of 
drug interactions (pDDI), which in turn may result in a 
higher prevalence of ADE (Grönroos et al., 1997; Smith 
et al., 1997; Vonbach et al., 2008). According to Vonbach 
et al. (2008), 47% of all pDDI at hospital discharge were 
the result of medication changes during hospitalization. 
However, Laroche et al. (2006) demonstrated that the 
prescription of anticholinergic and inappropriate drugs 
among geriatric inpatients decreased at discharge, showing 
that hospitalization could provide an opportunity to 
reassess pharmacological treatment.
In 2009, Brazil’s National Health Surveillance 
Agency (ANVISA, acronym in Portuguese) evaluated 
the influence of the pharmaceutical industry on the 
Brazilian health system. The resulting report showed 
that seven out of 10 public pharmacies did not have a 
supervising pharmacist (ANVISA, 2010). In a hospital 
setting, the constant presence of a pharmacist performing 
discharge planning and instructions is common, providing 
an important opportunity for therapy reassessment, 
particularly for elderly patients where the prevalence of 
multiple chronic conditions is generally high. 
Potentially inappropriate medications are a concern 
among health professionals given the risk of adverse drug 
reactions and hospitalization among older adults (Endres 
et al., 2016). The need for educational interventions 
addressing the risks associated with given medications 
targeting doctors, pharmacists and patients themselves is 
increasingly recognized (Wahab, 2015).
This study therefore aims to investigate the 
incidence of potential drug-drug interactions and the use 
of potentially inappropriate medication (PIM) at hospital 
admission, during hospitalization, and at discharge in order 
to explore the association between hospitalization and 
improvements in pharmacotherapy among elderly patients 
admitted to an internal medicine ward at a public teaching 
hospital that has a regular clinical pharmacist.
METHODS
A prospective cohort study was carried out using 
data from the medical records of an internal medicine 
ward at a teaching hospital (the University Hospital of the 
University of São Paulo, Brazil). The University Hospital 
(UH) is a 256-bed public hospital that has a 44-bed adult 
internal medicine ward. The UH offers medium complexity 
clinical services to University students and the local 
community. All admissions (712) were followed during 
a six-month period (between March and August 2006), 
which generated 8,371 drug orders. The UH Pharmacy 
Service is centralized and, except for intravenous drugs, 
attends only inpatients through an individualized drug 
dispensing system. All prescriptions have to be reviewed 
by the clinical pharmacist before drug dispensing. Each 
clinic receives individualized patient medication from 
the pharmacy service for a maximum period of 24 hours.
The study included all patients aged over 60 years, 
who were classified as ‘elderly’. Patients without drug 
orders who had been transferred to another ward or health 
care service and those for which the data was considered 
incomplete were excluded from the study sample. The 
following data was taken from the medical records: 
duration of hospital stay, patient identification (name, age, 
and sex), comorbidities (only those related to high blood 
pressure and diabetes mellitus, given the high prevalence 
of these conditions among the elderly and consequent 
chronic use of medications), and use of prescription 
drugs. After discharge, the primary diagnosis according 
to the ICD-10 classification was recorded as described in 
the discharge summary. The names of the prescribed and 
administered drugs, confirmed based on the signature of 
the head nurse on the patients’ prescriptions, were recorded 
for each day of the patients’ stay at hospital. The daily 
prescription includes all drugs administered during a 
patient’s hospital stay regardless of the route or frequency 
of administration, formulary status, or whether they were 
prescribed once as an additional drug or as a regular routine 
order. The drugs were classified using the Anatomical 
Therapeutic Chemical (ATC) classification system.
The profile of drug utilization and polypharmacy 
were described. Since the concept of polypharmacy is 
unclear, the number of patients using four, five and nine 
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different drugs was measured. Drug orders including two 
or more drugs were evaluated based on potential drug-
drug interactions (pDDI), determined and classified using 
the Micromedex’s DrugReax® software (Micromedex, 
2014) according to severity (major, moderate and minor) 
and scientific documentation categories (excellent, good, 
fair, poor, or unlikely). Only pDDI with excellent and 
good documentation were classified as well documented, 
while those classified as poor or unlikely were excluded. 
All pDDI during hospitalization were identified in 
order to measure the cumulative incidence of major and 
moderate pDDI among patients (total number of patients 
exposed to at least one pDDI divided by total number of 
patients). The incidence of pDDI at patient admission and 
discharge was also measured.
Potentially inappropriate medications were 
classified according to their appropriateness for elderly 
patients. This classification identifies patterns of drug 
use that unnecessarily place the elderly at risk of adverse 
drug events. The theoretical classification in this study 
was conducted independently from the diagnosis based 
on the updated Beers Criteria (AGS, 2015), except for 
the use of sliding scale insulin, which was not on the 
Beers list at the time of the study. The frequency of the 
use of inappropriate drugs among the elderly according 
to the Beers Criteria published in 2003 and 2012, both 
independent of diagnosis, have also been described (Fick 
et al., 2003).
The patients’ demographic and prescription data 
were presented as mean, median, and standard deviation 
expressed as percentage, using Microsoft Excel® version 
2007. The Shapiro-Wilks test was used to determine the 
normality of data. The chi-square test, Fisher’s exact test, 
and t-test were also performed. 
The research project was approved by the local ethics 
committee and registered in the National Information 
System on Ethics in Research Involving Human Beings 
(Sistema Nacional de Informação sobre Ética em 
Pesquisa envolvendo Seres Humanos - SISNEP; CAAE 
no 0024.0198.018-07).
RESULTS
A total of 712 elderly patients were admitted to 
the internal medicine ward of the UH During the study 
period, 316 of which met the inclusion criteria, resulting 
in the evaluation of 2,954 drug orders. Table I shows the 
demographic and clinical characteristics of the patients.
A comparison of prescription drug use on admission 
and discharge showed that there was a reduction in 
the number of patients using psycholeptics (73 versus 
32; p<0.001) and an increase in the number using 
antithrombotic agents (76 versus 144; p<0.001), drugs 
for acid-related disorders (99 versus 152; p<0.001), and 
lipid-modifying agents (58 versus 81; p=0.024). 
A set of 219 different prescription drugs were 
distributed throughout 13 ATC codes. Ten (4.6%) of 
these drugs could not be analyzed in relation to pDDI 
because they were not part of Micromedex’s DrugReax® 
database drugs list: benserazide, bromopride, cloxazolam, 
etoricoxib, fenoterol, lanatoside C, levomepromazine, 
metamizole, pericyazine, and salbutamol. 
The mean number of prescription drugs, level of 
polypharmacy, pDDI and/or potentially inappropriate 
medication (PIM) at admission, during hospitalization, 
and at discharge among patients and orders are described 
in Table II.
Table III summarizes the most frequent well 
documented and major pDDI observed in the evaluated 
drug orders, while the PIMs are described in Table IV.
DISCUSSION
The findings regarding mean age and length of 
hospital stay corroborate previous studies conducted in 
internal medicine wards at teaching hospitals in Brazil 
(Marusic et al., 2013; Passarelli, Jacob-Filho, Figueras, 
2005).
Cardiovascular diseases are common among Brazil’s 
general population and comprise a substantial portion of 
hospital admissions in the country, followed by respiratory 
diseases, excluding obstetric admissions (Brasil, 2015). 
Since this study was conducted during the winter months, 
it is consistent that bronchopneumonia was the most 
TABLE I - Demographic and clinical characteristics of elderly 
patients admitted to the HU-USP between March and August 
2006
Total number of patients 316
Female 162 (51.3%)
Average age ± SD, years 73.70±8.59
Blood pressure, n (%) 164 (51.9%)
Diabetes, n (%) 67 (21.2%)
Average length of stay ± SD, days 11.61±9.57
The most frequent discharge diagnoses, n (%)
Bronchopneumonia 73 (23.1%)
Acute myocardial infarction 43 (13.6%)
Cerebrovascular accident 15 (4.7%)
Congestive heart failure 11 (3.5%)
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frequently reported diagnosis. Bronchopneumonia, acute 
myocardial infarction, stroke, and heart failure are also 
documented as a frequent cause of hospitalization by 
other studies (Marusic et al., 2013; Passarelli, Jacob-Filho, 
Figueras, 2005).
The mean number of prescription drugs and number 
of patients exposed to at least nine drugs, one pDDI, 
major pDDI or PIM decreased during hospitalization 
in comparison. This finding reinforces the hypothesis 
that hospital admission can provide an opportunity to 
improve pharmacotherapy among the elderly when 
health professionals are aware of these factors and/or 
have support. The number of parameters increased 
during hospitalization – this is to be expected due to 
poorer health. A recently published study performed in 
a Norwegian hospital with 232 older adults (>75 years) 
observed that, apart from a significant decrease in the 
prescription of anticholinergics and benzodiazepines, the 
TABLE II - Mean number of prescription drugs, polypharmacy, patients exposed to potential drug interactions (pDDI) and/or 
potentially inappropriate medication (PIM) according Beers Criteria published in 2003, 2012, and 2015 in drug orders at admission, 
during hospitalization, and at discharge, HU-USP, between March and August 2006
Hospital 
Admission 
 (HA)
During 
hospitaliza-
tion  
(DH)
Hospital 
Discharge 
 (HD)
HA 
versus  
DH 
p
DH  
versus  
HD 
p
HA  
versus  
HD 
p
Number of 
drugs
Mean number 
of prescription 
drugs ±SD
5.73±2.92 6.25±2.82 4.36±2.99 <0.001 a <0.001 a <0.001 a
Polypharmacy
Patients that 
received a 
minimum of 
4 prescription 
drugs, n (%)
174 (55.1%) 226 (71.5%) 162 (51.3%) <0.001b <0.001b 0.339 b
Patients that 
received a 
minimum of 
5 prescription 
drugs, n (%)
147 (46.5%) 188 (59.5%) 126 (39.9%) <0.001b <0.001b 0.092 b
Patients that 
received a 
minimum of 
9 prescription 
drugs, n (%)
51 (16.1%) 77 (24.4%) 32 (10.1%) <0.001b <0.001b 0.025 b
pDDI
Exposed to at 
least one pDDI, 
n (%)
141 (44.5%) 247 (78.2%) 104 (32.8%) <0.001b <0.001b 0.002 b
Exposed to at 
least one major 
pDDI, n (%)
63 (19.9%) 159 (50.3%) 39 (12.2%) <0.001b <0.001b 0.010 b
PIM (2003)
Exposed to at 
least one PIM, 
n (%)
78 (24.7%) 153 (48.4%) 57 (18.0%) <0.001b <0.001b 0.041b
PIM (2012)
Exposed to at 
least one PIM, 
n (%)
123 (38.9%) 188 (59.5%) 92 (29.1%) <0.001b <0.001b 0.009b
PIM (2015)
Exposed to at 
least one PIM, 
n (%)
271 (85.8%) 236 (74.7%) 164 (51.9%) <0.001b <0.001b <0.001b
Key: SD = Standard Deviation – a =test-t; b = chi-square test
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TABLE III - Profile of the ten most frequent major and well documented potential drug interactions that the patients were exposed 
to during hospitalization in HU-USP between March and August 2006
Drug Drug
Hospital 
Admission 
 (HA)
During 
hospitalizati-
on  
(DH)
Hospital 
Discharge 
 (HD)
HA 
versus  
DH 
p
DH  
versus  
HD 
p
HA  
versus  
HD 
p
Anticoagulants 
or antiplatelet 
drugs
Any drug 64 (20.2%) 156 (49.4%) 131 (41.4%) <0.001a 0.046a <0.001a
Anticoagulant Antiplatelet 32 (10.1%) 110 (34.8%) 95 (30.1%) <0.001a 0.202a <0.001a
Aspirin Heparin 0 (0.0%) 91 (28.8%) 0 (0.0%) <0.001b <0.001b >0.999b
Aspirin Warfarin 2 (0.6%) 14 (4.4%) 1 (0.3%) 0.003b 0.001b 0.623b
Heparin Warfarin 0 (0.0%) 7 (2.2%) 0 (0.0%) 0.015b 0.015b >0.999b
Clopidogrel Omeprazole 8 (2.5%) 16 (5.1%) 16 (5.1%) 0.144b >0.999b 0.144b
Captopril Spironolacton 3 (0.9%) 12 (3.8%) 8 (2.5%) 0.033b 0.496b 0.222b
Captopril Potassium chloride 0 (0.0%) 6 (1.9%) 0 (0.0%) 0.030
b 0.030b >0.999b
Ciprofloxacyn Insulin 0 (0.0%) 7 (2.2%) 0 (0.0%) 0.015b 0.015b >0.999b
Simvastatin Warfarin 4 (1.3%) 9 (2.8%) 9 (2.8%) 0.262b >0.999b 0.262b
Key: a = chi-square test - b = Fisher’s exact test
TABLE IV - Description of potentially inappropriate medication prescribed for elderly inpatients of the UH between March and 
August 2006 according the Beers Criteria published in 2015
Drug Associated risk
Hospital 
Admission 
(HA)
n (%)
During 
hospitalization 
(DH)
n (%)
Hospital 
Discharge 
(HD)
n (%)
HA 
versus 
DH
p
DH 
versus 
HD
p
HA 
versus 
HD
p
Anticholinergics
Dexchlorphenira-
mine
Potent 
anticholinergic 
effects, prolonged 
sedation
15 (4.7%) 2 (0.6%) 3 (0.9%) 0.002a 0.686a 0.004a
Promethazine
Potent 
anticholinergic 
effects, prolonged 
sedation
10 (3.2%) 2 (0.6%) 3 (0.9%) 0.037a 0.686a 0.089a
Antispasmodics
Scopolamine
Anticholinergic 
effects; 
questionable 
effectiveness at 
doses tolerated 
by elderly
12 (3.8%) 2 (0.6%) 3 (0.9%) 0.007a 0.686a 0.020a
Cardiovascular
Amiodarone
Changes 
in the QT 
interval, severe 
arrhythmias, such 
as torsades de 
pointes
28 (8.9%) 16 (5.1%) 14 (4.4%) 0.607b 0.708b 0.254b
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Drug Associated risk
Hospital 
Admission 
(HA)
n (%)
During 
hospitalization 
(DH)
n (%)
Hospital 
Discharge 
(HD)
n (%)
HA 
versus 
DH
p
DH 
versus 
HD
p
HA 
versus 
HD
p
Digoxin  
(dose > 0,125mg)
Increased risk of 
digitalis toxicity 15 (4.7%) 8 (2.5%) 3 (0.9%) 0.144
a 0.222a 0.004a
Clonidine
High risk of 
orthostatic 
hypotension, 
depression, and 
sedation
5 (1.6%) 3 (0.9%) 0 (0.0%) 0.725a 0.249a 0.062a
Central nervous system
Antidepressants, alone or in combination
Amitriptyline
Anticholinergic 
effects and 
orthostatic 
hypotension
9 (2.8%) 4 (1.3%) 7 (2.2%) 0.262a 0.545a 0.801a
Imipramine
Anticholinergic 
effects and 
orthostatic 
hypotension
1 (0.3%) 1 (0.3%) 1 (0.3%) >0.999a >0.999a >0.999a
Nortriptyline
Anticholinergic 
effects and 
orthostatic 
hypotension
3 (0.9%) 3 (0.9%) 3 (0.9%) >0.999a >0.999a >0.999a
Antipsychotics, first (conventional) and second (atypical) generation
Chlorpromazine
Increased risk of 
cerebrovascular 
accident
0 (0.0%) 4 (1.3%) 0 (0.0%) 0.124a 0.124a >0.999a
Haloperidol
Increased risk of 
cerebrovascular 
accident
7 (2.2%) 9 (2.8%) 5 (1.6%) 0.801a 0.419a 0.772a
Barbiturates
Phenobarbital
High risk 
of physical 
dependence, 
greater risk of 
overdose at low 
dosages
4 (1.3%) 4 (1.3%) 2 (0.6%) >0.999a 0.686a 0.686a
Benzodiazepines
Clonazepam
Sedation; 
possibility of 
falls and fractures
7 (2.2%) 0 (0.0%) 0 (0.0%) 0.015a >0.999a 0.015a
Diazepam
Sedation; 
possibility of 
falls and fractures
54 (17.1%) 23 (7.3%) 13 (4.1%) <0.001b 0.129b <0.001b
Lorazepam
Sedation; 
possibility of 
falls and fractures
0 (0.0%) 1 (0.3%) 0 (0.0%) >0.999a >0.999a >0.999a
TABLE IV - Description of potentially inappropriate medication prescribed for elderly inpatients of the UH between March and 
August 2006 according the Beers Criteria published in 2015 (cont.)
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Drug Associated risk
Hospital 
Admission 
(HA)
n (%)
During 
hospitalization 
(DH)
n (%)
Hospital 
Discharge 
(HD)
n (%)
HA 
versus 
DH
p
DH 
versus 
HD
p
HA 
versus 
HD
p
Sulfonylureas, long-duration
Glyburide
Higher risk of 
severe prolonged 
hypoglycemia in 
older adults
16 (5.1%) 9 (2.8%) 9 (2.8%) 0.220a >0.999a 0.220a
Gastrointestinal
Metoclopramide
Can cause 
extrapyramidal 
effects, mainly in 
frail older adults
17 (5.4%) 59 (18.7%) 12 (3.8%) <0.001b <0.001b 0.342b
Mineral oil 
given orally Risk of aspiration 60 (19.0%) 17 (5.4%) 20 (6.3%) <0.001
b 0.611b <0.001b
Proton-pump 
inhibitors
Risk of 
Clostridium 
difficile infection 
and bone loss and 
fractures
61 (19.3%) 100 (31.6%) 87 (27.5%) <0.001b 0.257b 0.015b
Key: a = Fisher’s exact test - b= chi-square test
TABLE IV - Description of potentially inappropriate medication prescribed for elderly inpatients of the UH between March and 
August 2006 according the Beers Criteria published in 2015 (cont.)
number of prescription drugs and prevalence of PIMs 
were not affected by hospitalization. The study used the 
Norwegian General Practice (NORGEP) criteria for PIM. 
The authors also found that the medication profile was 
more appropriate among elderly patients in the geriatric 
ward and a greater reduction of dosage and prescription 
of PIMs in comparison to other patients (Kersten et al., 
2015). 
Certain changes in drug prescription profiles were 
found before and after hospitalization, such as an increase 
in the proportion of patients using antithrombotic agents 
and lipid modifying agents due to the high prevalence 
of cardiovascular diseases. A reduction in the number 
of patients who were prescribed psycholeptics, mainly 
diazepam, was highlighted, as reported by the Norwegian 
study (Kersten et al., 2015). A prospective cohort study 
with patients aged 70 years and over in Australian 
hospitals investigated the use of benzodiazepines in 
acute care settings and explored the association with falls 
before (during a 90-day period prior to admission) and 
during hospitalization. Although no statistically significant 
difference was found between falls among users and non-
users of these drugs during hospitalization and prior to 
admission, a positive association was observed between 
history of falls and use of diazepam at admission when 
compared with all other benzodiazepine users (odds ratio 
3.0; 95 % CI 1.1-8.5; p = 0.036) (Ballokova et al., 2014).
On the other hand, an increase in the prescription 
of drugs for acid-related disorders, particularly proton-
pump inhibitors, was observed. The use of proton-pump 
inhibitors is common among patients treated with multiple 
drugs. According to a number of studies, the prescription 
of these drugs is inappropriate in 40 to 80% of patients 
(Ahrens, Behrens, Himmel et al., 2012). Although, in 
general, proton-pump inhibitors are well tolerated, it is 
important to note that they may cause clinically relevant 
drug interactions and their safety for long-term use 
remains unclear (Pilotto et al., 2010). Recent studies 
have suggested that there is an association between the 
prolonged use of proton-pump inhibitors and enteric 
infections caused by Clostridium Difficile, which increases 
the risk of community-acquired pneumonia and hip 
fractures (Pilotto et al., 2010; Thomson et al., 2010).
According to the literature, the incidence of pDDI 
is directly correlated with number of prescription drugs 
(Björkman et al., 2002; Cruciol-Souza, Thomson, 2006; 
Marusic et al., 2013; Passarelli, Jacob-Filho, Figueras, 
2005; Secoli et al., 2010). Studies have shown that the 
number of prescription drugs, pDDI, and the incidence 
of major pDDI were significantly lower at hospital 
discharge than at admission, which may be related to the 
lower number of prescription drugs. A study of a sample 
of outpatients also found that most patients (82%) using 
five or more medications are more likely to be exposed 
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to pDDI (Holbrook et al., 2005). A community study 
conducted in Brazil also revealed that the risk of pDDI is 
three times greater among older adults using five or more 
drugs (Secoli et al., 2010). Thus, the decrease in both pDDI 
and the incidence of major pDDI at discharge is consistent 
with a reduction in the total number of prescription drugs.
Most studies addressing the incidence of pDDI 
among the elderly were performed in outpatient health care 
services (Björkman et al., 2002; Gaeta et al., 2002; Obreli 
Neto et al., 2012; Secoli et al., 2010). An investigation 
involving six European countries reported that 46% 
of elderly outpatients had been exposed to at least one 
clinically relevant pDDI (Björkman et al., 2002). In Brazil, 
Secoli et al (2010) found that 54.9% of elderly outpatients 
who use two or more drugs had been exposed to at least 
one pDDI and that pDDI prevalence was 26.5% (Secoli et 
al., 2010). Other Brazilian studies observed that 15% of 
ADR in a public hospital were related to drug interactions 
(Passarelli, Jacob-Filho, Figueras, 2005) that 8% of elderly 
primary care patients had been exposed to some kind of 
pDDI, and that 6.5% of ADR were due to DDI (Obreli 
Neto et al., 2012).
The proportion of patients exposed to at least one 
pDDI or one major pDDI at admission was 44.5% and 
19.9%, respectively. A study conducted in 70 internal 
medicine and geriatric wards in Italy (total of 2,712 
elderly patients) observed that 1,642 patients (60.5%) 
had been exposed to one or more pDDI and 512 (18.9%) 
to one severe pDDI at hospital admission (Pasina et al., 
2013), while 85.6% of elderly patients (190 out of a total 
of 222) discharged from the internal medicine ward of 
a tertiary-level hospital in Croatia had been exposed to 
at least one pDDI (Marusic et al., 2013). Furthermore, 
69.1% of patients discharged from an Italian hospital 
(1,598 out of a total of 2,314) were exposed to at least 
one pDDI and 24.2% (561) to one severe pDDI (Pasina et 
al., 2013). Several studies have reported a larger number 
of pDDI and patients exposed to potentially severe DDIs 
at hospital discharge in comparison to admission (Egger, 
Drewe, Schlienger, 2003; Pasina et al., 2013; Vonbach et 
al., 2008). Thus, it can be assumed that the exposure of 
elderly outpatients to ADE is the same as that of inpatients.
The pDDI and major pDDI profile observed by this 
study are common and to be expected in a hospital setting. 
Although a potential risk, they cannot be considered 
medication errors or contraindicated medications. In 
fact, most associations are routinely used to obtain better 
therapeutic results and only require patient monitoring. 
Available evidence regarding the association between 
antiplatelet and an anticoagulant drugs such as aspirin 
and heparin is not conclusive about the risks and benefits 
of combining anticoagulant and antiplatelet medications 
to reduce cardiovascular events. That is to say that there 
is no consensus about the harmful effects of combined 
use (Lane et al., 2013; Massel, Little, 2013). There is 
also considerable debate about the negative impact of the 
combined use of proton-pump inhibitors and clopidogrel, 
one of the most frequent major pDDI. Recently published 
reviews concluded that platelet function studies do not 
demonstrate a consistent interaction between clopidogrel 
and PPI. To date, studies have failed to determine the risk 
of adverse cardiovascular effects due to the heterogeneous 
nature of samples and methodology (Focks et al., 2013; 
Kwok, Loke, 2012). Furthermore, the concomitant 
administration of captopril and spironolactone or 
potassium supplements is one of the most frequently 
described major pDDI in both outpatients and inpatients 
(Obreli Neto et al., 2012). Although this combination may 
increase the risk of arrhythmias, the interaction is safe in 
a hospital setting where a potassium test is part of routine 
laboratory monitoring. 
In Brazil, a study involving a sample of 186 elderly 
internal medicine inpatients and using Beers Criteria 
published in 2003 observed that 115 patients (61.8%) were 
exposed to at least one ADR, principally (55.7%) during 
hospitalization (Passarelli, Jacob-Filho, Figueras, 2005). 
The use of potentially inappropriate medication (PIM) 
leads to a two-fold increase in the risk of ADR. In addition, 
the use of PIMs was associated with a larger number of 
prescription drugs and adverse drug reactions (Passarelli, 
Jacob-Filho, Figueras, 2005).
Regarding length of hospital stay, 236 (74.7%) 
elderly patients were exposed to at least one PIM. 
However, these results are not comparable with others 
studies due to changes in the Beers Criteria list in 2015. 
The main change to the last version of the list was the 
inclusion of proton-pump inhibitors, which has an impact 
on the results of this study. In fact, omeprazole was the only 
PIM whose prescription increased at discharge and was 
the most prescribed PIMs during and after hospitalization. 
Prevalence rates vary considerably across different 
studies involving inpatients: 5.3 - 40.7% in the USA, 
16.3 - 52.6% in Canada, 19.8% in Europe, and 38.5% in 
Portugal (Curtis et al., 2004; Fialová et al., 2005; Maio, 
Del Canale, Abouzaid, 2010; Nyborg, Straand, Brekke, 
2012; Oliveira Martins et al., 2006). In Brazil, prevalence 
rates range between 15.6% and 41% (Faustino, Passarelli, 
Jacob-Filho, 2013; Passarelli, Jacob-Filho, Figueras, 
2005). However, it is important to take into account which 
version of the Beers Criteria was used in each analysis. The 
prevalence of PIMs at hospital admission and discharge 
was 85.8% and 51.9%, respectively, However, it should 
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be noted that these rates are influenced by the prescription 
of omeprazole. It is also important to note that it is often 
difficult to replacing certain PIMs because of the lack of 
availability of drugs in in São Paulo’s primary healthcare 
service.
Limitations of this study include the fact that there 
are few comparable studies involving internal medicine 
wards and the wide range of prevalence of pDDI and PIMs 
due to contrasting methodologies used in the literature. 
In addition, several medications on the Beers Criteria list 
are unavailable in countries other than the United States, 
whereas a number of drugs sold in Brazil, including those 
observed in this study, are not listed. The high prevalence 
of pDDI and PIMs found by this study does not suggest 
an unsatisfactory level of prescribing quality since clinical 
decisions are made on an individual basis, considering 
the patient’s medical condition and the hospital drug 
formulary. 
CONCLUSION
The findings of this study suggest that the admission 
to hospital ward that has a clinical pharmacist may 
provide a good opportunity to review and adjust chronic 
disease therapy, especially among elderly inpatients. 
The close monitoring of inpatients during their stay 
in hospital enables the identification and solution of 
previously undetected problems that are often present in 
outpatients. However, quality health care services require 
a multidisciplinary environment that ensures the free flow 
of information between hospital physicians and general 
practitioners.
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